| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |